Abstract: A thermal management system for an aircraft includes a first gas turbine engine, first thermal bus, first heat exchanger, one or more first ancillary systems, vapour compression system, one or more second ancillary systems and second heat exchanger. A waste heat energy generated by a first gas turbine engine, and a first ancillary system, transfers to the first heat transfer fluid. A waste heat energy generated by a second ancillary system transfers to a second heat transfer fluid, and the second heat exchanger transfers the waste heat energy from the second heat transfer fluid to the first heat transfer fluid. The waste heat energy generated by a second ancillary system transfers to the first heat transfer fluid, and the first heat exchanger transfers the waste heat energy to a dissipation medium. The waste heat energy transferred to the second heat transfer fluid ranges from 20 kW to 300 kW.

Abstract: A thermal management system for an aircraft includes a first gas turbine engine, first thermal bus, first heat exchanger, one or more first ancillary systems, vapour compression system, one or more second ancillary systems and second heat exchanger. A waste heat energy generated by a first gas turbine engine, and a first ancillary system, transfers to the first heat transfer fluid. A waste heat energy generated by a second ancillary system transfers to a second heat transfer fluid, and the second heat exchanger transfers the waste heat energy from the second heat transfer fluid to the first heat transfer fluid. The waste heat energy generated by a second ancillary system transfers to the first heat transfer fluid, and the first heat exchanger transfers the waste heat energy to a dissipation medium. The waste heat energy transferred to the second heat transfer fluid ranges from 20 kW to 300 kW.

Abstract: A thermal management system for an aircraft comprises a first gas turbine engine, a first thermal bus, a first heat exchanger, and a chiller. The first thermal bus comprises a first heat transfer fluid, with the first heat transfer fluid being in fluid communication, in a closed loop flow sequence, between the first gas turbine engine, the first heat exchanger, and the chiller. Waste heat energy generated by the first gas turbine engine, is transferred to the first heat transfer fluid. The chiller is configured to lower a temperature of the first heat transfer fluid prior to the first heat transfer fluid being circulated through the gas turbine engine. The first heat is exchanger is configured to transfer the waste heat energy from the first heat transfer fluid to a dissipation medium.

Abstract: A thermal management system for an aircraft includes a first thermal bus including one or more first heat sources, a heat sink, a vapour compression system, and one or more second heat sources. The vapour compression system includes a compressor, a condenser, a receiver, a first side of a recuperator, an expansion valve, an evaporator, a second side of the recuperator, and the compressor. A first heat flow (Q1) of waste heat energy generated by the first heat sources is transferred via the first heat transfer fluid to the heat sink. A second heat flow (Q2) of waste heat energy generated by the second heat source(s) being transferred via the evaporator to a refrigerant. A third heat flow (Q3) of heat energy in the refrigerant is transferred via the condenser to the first heat transfer fluid. The controller is configured to ensure that: 1.1*Q2<Q3<3.0*Q2.

Abstract: A load bearing implant provided with an auto-generator generating an electric charge. One or more nanogenerators are incorporated into or onto the load bearing implant or a delivery vehicle. It is believed that electric charge improves the healing of damaged/injured tissues.

Abstract: An implant provided with an auto-generator generating an electric charge. One or more nanogenerators are incorporated into or onto the implant or used as stand-alone devices. It is believed that electric charge improves the healing of damaged/injured tissues.

Abstract: This disclosure relates to a method for estimating a solution to a problem represented by a Hamiltonian on a quantum computer having a quantum state. A classical computer determines a trial state and evolves the quantum state of the quantum computer based on the trial state. The computer then determines estimates for expectation values with respect to the trial state of powers of the Hamiltonian based on measurements from the quantum computer and calculates an estimate of the solution based on the estimates for the expectation values of powers of the Hamiltonian for the trial state. The computer then repeated updates the trial state and repeats the measuring steps to iteratively improve the estimate of the solution.

Abstract: An orthopedic prosthesis for stimulating bone growth may include a substrate having at least one bone-facing surface and at least one internal surface, at least one piezoelectric nanostructure coupled to the at least one bone-facing surface of the substrate, at least one charge storing material placed within the orthopedic prosthesis proximate the at least one internal surface, and an interconnect in electrical communication with the at least one piezoelectric nanostructure and the charge storing material. The at least one piezoelectric nanostructure may be configured to generate an electric charge in response to at least one mechanical force applied to the at least one piezoelectric nanostructure and the interconnect may be configured to transfer the electric charge to the at least one charge storing material to promote bone in-growth within the orthopedic prosthesis and/or on the at least one bone-facing surface.

Abstract: A recyclable, laminated polyolefin-based film structure comprises two or more film plies laminated to each other. Each of the laminated film plies comprises one or more polyolefin-based films. The film structure has an energy-cured coating layer disposed on the outermost outward facing surface of the film structure and a printed ink layer on an interior surface of one of the polyolefin-based polyolefin layers. In certain embodiments, the outermost surface of the laminated polyolefin-based film structure has a melting temperature which is at least 100 degrees Celsius, and more preferably 180 degrees Celsius, higher than a melting temperature of the innermost surface of the laminated polyolefin-based film structure.

Abstract: Systems and methods are disclosed for digital design tools. One example method comprises obtaining an electronic model of a structure, the electronic model including a objects, and the objects representing physical objects to be constructed. Dependencies between the objects are determined, with the determined dependencies indicating that a first object is to be constructed prior to a second object. Construction orderings are generated based on the determined dependencies, with each construction ordering indicating a unique order in which the objects are to be constructed. A user interface is presented via a user device describing the construction orderings, with a system being configured to trigger updates to the electronic model in response to received material changes associated with the electronic model.

Abstract: The present invention relates to in vivo imaging and in particular to magnetic resonance imaging (MRI). Provided by the present invention is a pharmaceutical formulation suitable for use in an MRI procedure and which offers advantages over known such formulations. A particular dose of the pharmaceutical formulation of the invention is also envisioned as well as the use of said dose in a method of in vivo imaging. This present invention provides for simultaneous administration of a liver specific agent and a second MR contrast agent that is capable of better/further enhancing the dynamic vascular phase in a patient. The method of the invention has the advantage of simplicity and patient comfort, compared to sequential injections. Furthermore, the method of the invention provides the advantage that it can enable a lower cumulative dose of contrast agents.

Abstract: The present application provides a means for differential diagnosis of Parkinson's disease and the clinically similar Parkinsonian disorders multiple system atrophy with predominantly Parkinsonian features (MSA-P) and progressive supranuclear palsy (PSP).

Abstract: A method implemented onto a computer device for unification of elemental sequences of syntaxes and graphical user interfaces into a unified syntax direct interface object based contemporary file state; also, comprising Direct interface integration systems and deployment (or equivalent) of electronic syntaxes and/or representations (visual based or other); and unification of electronic navigation systems and transaction based payment systems as well as interactive graphical user interfaces; Further comprising (but not limited to) integrated user controller interface modules with data input and manipulation methods and processes.

Abstract: A graphical user interface including a controller for redistributing funds between a first account and a second account. The controller includes a slidable element positionable over a fixed background element to define a first segment and a second segment of the background element. A length of the first segment is representative of a balance of the first account, and a length of the second segment is representative of a balance of the second account.

Abstract: The present application provides a means for differential diagnosis of Parkinson's disease and the clinically similar Parkinsonian disorders multiple system atrophy with predominantly Parkinsonian features (MSA-P) and progressive supranuclear palsy (PSP).

Abstract: Systems and methods are disclosed for digital design tools. One example method comprises obtaining an electronic model of a structure, the electronic model including a objects, and the objects representing physical objects to be constructed. Dependencies between the objects are determined, with the determined dependencies indicating that a first object is to be constructed prior to a second object. Construction orderings are generated based on the determined dependencies, with each construction ordering indicating a unique order in which the objects are to be constructed. A user interface is presented via a user device describing the construction orderings, with a system being configured to trigger updates to the electronic model in response to received material changes associated with the electronic model.

Abstract: A method implemented onto a computer device for unification of elemental sequences of syntaxes and graphical user interfaces into a unified syntax direct interface object based contemporary file state; also, comprising Direct interface integration systems and deployment (or equivalent) of electronic syntaxes and/or representations (visual based or other); and unification of electronic navigation systems and transaction based payment systems as well as interactive graphical user interfaces; Further comprising (but not limited to) integrated user controller interface modules with data input and manipulation methods and processes.

Abstract: A computer-assisted method for alerting a user of a potential negative balance condition in a financial account. The method includes estimating a future account balance of the financial account and determining whether the future account balance will be a negative value. The method also includes generating for display, in a graphical format, an alert to the user that signifies when the future account balance is the negative value.

Abstract: The present invention relates to in vivo imaging and in particular to magnetic resonance imaging (MRI). Provided by the present invention is a pharmaceutical formulation suitable for use in an MRI procedure and which offers advantages over known such formulations. A particular dose of the pharmaceutical formulation of the invention is also envisioned as well as the use of said dose in a method of in vivo imaging. This present invention provides for simultaneous administration of a liver specific agent and a second MR contrast agent that is capable of better/further enhancing the dynamic vascular phase in a patient. The method of the invention has the advantage of simplicity and patient comfort, compared to sequential injections. Furthermore, the method of the invention provides the advantage that it can enable a lower cumulative dose of contrast agents.

Abstract: The present invention relates to a method of in vivo imaging with meta-[123I]iodobenzylguanidine ([123I]mIBG) and more particularly wherein said method is used to stratify a defined subset of subjects with heart failure into particular treatment regimens.